Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GGHCX vs LHCOX overlap: 49% of top holdings shared

Bottom line

How much do GGHCX and LHCOX overlap?

49% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 38.3% of GGHCX's assets and 38.4% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

GGHCXLHCOX
Weight overlap (top 25)49%
Shared holdings10
Weight in shared holdings38.3%38.4%
Total positions8261
Expense ratio1.07%0.68%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings GGHCX and LHCOX have in common

Holding% of GGHCX% of LHCOXOverlap
Eli Lilly and Co.10.59%10.40%10.40%
Johnson & Johnson6.76%4.96%4.96%
UnitedHealth Group Inc.6.17%5.39%5.39%
Gilead Sciences, Inc.3.63%3.53%3.53%
CVS Health Corp.2.52%3.33%2.52%
Guardant Health, Inc.2.04%2.61%2.04%
Vertex Pharmaceuticals Inc.2.01%2.24%2.01%
Edwards Lifesciences Corp.1.56%1.78%1.56%
Thermo Fisher Scientific Inc.1.55%2.31%1.55%
BridgeBio Pharma, Inc.1.43%1.84%1.43%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. Merck & Co., Inc. — 4.59%
  3. AbbVie Inc. — 4.03%
  4. argenx SE — 3.24%
  5. Welltower Inc. — 2.34%
  6. BrightSpring Health Services, Inc. — 2.20%
  7. Royalty Pharma PLC — 2.13%
  8. Cardinal Health, Inc. — 2.10%
  9. Invesco Private Government Fund — 1.80%
  10. Axsome Therapeutics, Inc. — 1.58%
  11. Invesco Treasury Portfolio — 1.56%
  12. Waters Corp. — 1.41%
  13. IQVIA Holdings Inc. — 1.32%
  14. U C B S.a. — 1.24%
  15. Ligand Pharmaceuticals Inc. — 1.18%

Only in LHCOX

  1. Novartis AG — 4.19%
  2. Natera Inc — 3.60%
  3. Galderma Group AG — 2.60%
  4. Cogent Biosciences Inc — 2.27%
  5. 10X Genomics Inc — 2.16%
  6. BeOne Medicines Ltd — 2.06%
  7. Ascendis Pharma A/S — 1.99%
  8. AstraZeneca PLC — 1.97%
  9. Madrigal Pharmaceuticals Inc — 1.91%
  10. Revolution Medicines Inc — 1.67%
  11. Arrowhead Pharmaceuticals Inc — 1.52%
  12. Protagonist Therapeutics Inc — 1.44%
  13. Dianthus Therapeutics Inc — 1.44%
  14. Adaptive Biotechnologies Corp — 1.42%
  15. Illumina Inc — 1.42%

Asset mix

Asset typeGGHCXLHCOX
Stocks97.5%98.2%
Cash & short-term funds8.8%0.8%
Repurchase agreements—1.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryGGHCXLHCOX
US93.5%78.5%
CH2.7%8.8%
NL3.4%2.2%
GB3.1%2.0%
DK1.1%2.0%
BE1.2%1.4%
IL0.4%1.2%
JP—1.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do GGHCX and LHCOX overlap?
About 49% by weight. 10 securities appear in both funds' top 25 holdings; they make up 38.3% of GGHCX's assets and 38.4% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GGHCX and LHCOX have in common?
The largest shared holdings are Eli Lilly and Co., UnitedHealth Group Inc., Johnson & Johnson, Gilead Sciences, Inc., CVS Health Corp..
Should I own both GGHCX and LHCOX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GGHCX or LHCOX?
GGHCX is broader, with 82 positions versus 61 for LHCOX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.